Experimental cocktail targets tough lung cancer

NCT ID NCT05353439

First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 28 times

Summary

This early-phase trial tests a three-drug combination (tazemetostat, topotecan, and pembrolizumab) in adults whose small cell lung cancer has returned after prior treatment. The goal is to find the safest dose and see if the combo can shrink or stabilize the cancer. About 18 participants will be enrolled.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Johns Hopkins University/Sidney Kimmel Cancer Center

    Baltimore, Maryland, 21287, United States

  • Keck Medicine of USC Koreatown

    Los Angeles, California, 90020, United States

  • Los Angeles General Medical Center

    Los Angeles, California, 90033, United States

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia, 20007, United States

  • Montefiore Medical Center - Moses Campus

    The Bronx, New York, 10467, United States

  • Montefiore Medical Center-Einstein Campus

    The Bronx, New York, 10461, United States

  • NCI - Center for Cancer Research

    Bethesda, Maryland, 20892, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California, 90033, United States

  • USC Norris Oncology/Hematology-Newport Beach

    Newport Beach, California, 92663, United States

  • UT Southwestern/Simmons Cancer Center-Dallas

    Dallas, Texas, 75390, United States

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California, 95817, United States

  • University of Kentucky/Markey Cancer Center

    Lexington, Kentucky, 40536, United States

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, 27157, United States

  • Wake Forest University at Clemmons

    Clemmons, North Carolina, 27012, United States

Conditions

Explore the condition pages connected to this study.